Silence Therapeutics (SLN) Other Non Operating Income (2020 - 2025)
Historic Other Non Operating Income for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to $1.9 million.
- Silence Therapeutics' Other Non Operating Income rose 11697.09% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 15486.82%. This contributed to the annual value of $4.5 million for FY2024, which is 26932.98% up from last year.
- Silence Therapeutics' Other Non Operating Income amounted to $1.9 million in Q3 2025, which was up 11697.09% from -$6.6 million recorded in Q2 2025.
- Silence Therapeutics' Other Non Operating Income's 5-year high stood at $357.1 million during Q1 2021, with a 5-year trough of -$357.0 million in Q3 2021.
- Over the past 5 years, Silence Therapeutics' median Other Non Operating Income value was -$106492.8 (recorded in 2021), while the average stood at -$311203.5.
- Within the past 5 years, the most significant YoY rise in Silence Therapeutics' Other Non Operating Income was 55326.31% (2024), while the steepest drop was 160951.57% (2024).
- Over the past 5 years, Silence Therapeutics' Other Non Operating Income (Quarter) stood at -$106492.8 in 2021, then crashed by 434.19% to -$568870.2 in 2022, then crashed by 587.04% to -$3.9 million in 2023, then soared by 502.67% to $15.7 million in 2024, then tumbled by 87.71% to $1.9 million in 2025.
- Its Other Non Operating Income stands at $1.9 million for Q3 2025, versus -$6.6 million for Q2 2025 and -$3.8 million for Q1 2025.